Maternal preeclampsia is associated with an increased risk of retinopathy of prematurity

Hilal Ozkan1, Merih Cetinkaya, Nilgun Koksal

  • 1Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Uludag University, Bursa, Turkey.

Insights

Maternal preeclampsia significantly increases the risk and severity of retinopathy of prematurity (ROP) in preterm infants. Further research is needed to fully understand this association.

Area of Science:

  • Neonatology
  • Ophthalmology
  • Perinatology

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in preterm infants.
  • Preeclampsia, a common pregnancy complication, may influence fetal development and neonatal outcomes.

Purpose of the Study:

  • To investigate the impact of maternal preeclampsia on the incidence and severity of ROP in preterm infants.
  • To determine if preeclampsia is an independent risk factor for ROP development.

Main Methods:

  • Prospective study comparing preterm infants (≤32 weeks) born to mothers with preeclampsia versus normotensive mothers.
  • ROP classification using the International Classification of Retinopathy of Prematurity Revisited.
  • Ophthalmological examinations initiated at 4 weeks postnatal age.

Main Results:

  • ROP was diagnosed in 28% of 385 infants.
  • Incidence of ROP was significantly higher in infants of preeclamptic mothers (40.5%) compared to controls (22.4%).
  • Infants born to preeclamptic mothers showed higher rates of ROP stages 1, 2, and 3.

Conclusions:

  • Maternal preeclampsia is associated with an increased risk and severity of ROP in preterm neonates.
  • Preeclampsia may be a predictive factor for ROP development.
  • The precise mechanisms linking maternal preeclampsia to ROP require further investigation.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...